Percutaneous Mitral Valve Repair in Cardiogenic Shock: Mitra-Shock Study (MSS)

San Donato Group (GSD)

Status: Unknown

Conditions: Mitral Regurgitation Functional

Treatments: Device: MitraClip implantation

Study type: Observational

Funder types: Other

Identifiers

NCT04399499

MITRA-SHOCK-2020

Details and patient eligibility

About

Cardiogenic shock (CS) is a medical emergency and a frequent cause of death. CS can be complicated and/or precipitated by mitral regurgitation (MR). The efficacy of percutaneous treatment of MR in patients with cardiogenic shock is unknown. The aims of the study will be to analyse the efficacy of MitraClip therapy on early (30 days) and midterm mortality (6 months) as well as the predictors of outcomes. Investigators will also report the rate of periprocedural complications such as minor and major bleeding, vessel injury and Acute Kidney Injury (AKI).

It is a multicenter retrospective observational study on CE marked medical device (MitraClip® System). Retrospective time range: from 01/01/2012 to 01/01/2020

Enrollment: 30 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• older than 18 years old

Exclusion criteria

• multiorgan failure,
• VA-ECMO,
• inadequate peripheral access because of vascular disease,
• not suitable mitral valve anatomy.